Kriti Nutrients Limited (BOM:533210)
India · Delayed Price · Currency is INR 92.00
-1.70 (-1.81%)
At close: May 8, 2026
Kriti Nutrients Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 9,215 | 7,343 | 6,844 | 7,969 | 7,529 |
Other Revenue | 79.69 | - | - | - | - |
| 9,295 | 7,343 | 6,844 | 7,969 | 7,529 | |
Revenue Growth (YoY) | 26.57% | 7.30% | -14.12% | 5.84% | 9.10% |
Cost of Revenue | 8,212 | 6,324 | 5,744 | 7,165 | 6,804 |
Gross Profit | 1,082 | 1,019 | 1,099 | 803.7 | 725.25 |
Selling, General & Admin | 197.21 | 237.99 | 208.9 | 154.19 | 141.63 |
Other Operating Expenses | 371.14 | 300.96 | 268.16 | 337.6 | 389.94 |
Operating Expenses | 625.85 | 593.35 | 523.97 | 533.42 | 568.91 |
Operating Income | 456.58 | 425.85 | 575.27 | 270.27 | 156.34 |
Interest Expense | -5.48 | -3.54 | -10.85 | -30.65 | -17.17 |
Interest & Investment Income | - | 53.06 | 29.14 | 19.03 | 13.32 |
Currency Exchange Gain (Loss) | - | 11.92 | 10.58 | 16.3 | 19.15 |
Other Non Operating Income (Expenses) | - | 0.71 | -0.15 | 4.38 | -2.81 |
EBT Excluding Unusual Items | 451.1 | 487.99 | 603.98 | 279.32 | 168.83 |
Gain (Loss) on Sale of Investments | - | 9.77 | 1.87 | - | -0.51 |
Pretax Income | 451.1 | 497.76 | 605.85 | 279.32 | 168.32 |
Income Tax Expense | 112.7 | 127.52 | 152.98 | 71.34 | 45.26 |
Net Income | 338.41 | 370.24 | 452.87 | 207.98 | 123.05 |
Net Income to Common | 338.41 | 370.24 | 452.87 | 207.98 | 123.05 |
Net Income Growth | -8.60% | -18.25% | 117.74% | 69.02% | -18.27% |
Shares Outstanding (Basic) | 50 | 50 | 50 | 50 | 50 |
Shares Outstanding (Diluted) | 50 | 50 | 50 | 50 | 50 |
Shares Change (YoY) | -0.24% | - | - | - | - |
EPS (Basic) | 6.77 | 7.39 | 9.04 | 4.15 | 2.46 |
EPS (Diluted) | 6.77 | 7.39 | 9.04 | 4.15 | 2.46 |
EPS Growth | -8.38% | -18.25% | 117.80% | 68.98% | -18.27% |
Free Cash Flow | 587.24 | 273.48 | 409.62 | 134.13 | -193.72 |
Free Cash Flow Per Share | 11.75 | 5.46 | 8.18 | 2.68 | -3.87 |
Dividend Per Share | - | 0.300 | 0.300 | 0.250 | 0.180 |
Dividend Growth | - | - | 20.00% | 38.89% | - |
Gross Margin | 11.64% | 13.88% | 16.06% | 10.09% | 9.63% |
Operating Margin | 4.91% | 5.80% | 8.41% | 3.39% | 2.08% |
Profit Margin | 3.64% | 5.04% | 6.62% | 2.61% | 1.63% |
Free Cash Flow Margin | 6.32% | 3.72% | 5.99% | 1.68% | -2.57% |
EBITDA | 514.08 | 476.18 | 616.93 | 307.82 | 188.18 |
EBITDA Margin | 5.53% | 6.49% | 9.01% | 3.86% | 2.50% |
D&A For EBITDA | 57.5 | 50.33 | 41.67 | 37.55 | 31.84 |
EBIT | 456.58 | 425.85 | 575.27 | 270.27 | 156.34 |
EBIT Margin | 4.91% | 5.80% | 8.41% | 3.39% | 2.08% |
Effective Tax Rate | 24.98% | 25.62% | 25.25% | 25.54% | 26.89% |
Revenue as Reported | 9,295 | 7,421 | 6,888 | 8,013 | 7,562 |
Advertising Expenses | - | 32.33 | 20.65 | 18.51 | 19.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.